ZipRecruiter

Log In

1

Clinical Evaluation Jobs (NOW HIRING)

Abbott

Scientist, Clinical Research

Los Angeles, CA

Writes / manages clinical trial protocols, protocol amendments, clinical study project timelines, clinical evaluations (planning and reports), risk master lists, clinical trial registrations and ...

Abbott

Scientist, Clinical Research

Sylmar, CA · On-site

Writes / manages clinical trial protocols, protocol amendments, clinical study project timelines, clinical evaluations (planning and reports), risk master lists, clinical trial registrations and ...

Abbott

Writes / manages clinical trial protocols, protocol amendments, clinical study project timelines, clinical evaluations (planning and reports), risk master lists, clinical trial registrations and ...

Abbott

Scientist, Clinical Research

Sylmar, CA

Writes / manages clinical trial protocols, protocol amendments, clinical study project timelines, clinical evaluations (planning and reports), risk master lists, clinical trial registrations and ...

Abbott

Scientist, Clinical Research

Sylmar, CA

Writes / manages clinical trial protocols, protocol amendments, clinical study project timelines, clinical evaluations (planning and reports), risk master lists, clinical trial registrations and ...

Abbott

Scientist, Clinical Research

Los Angeles, CA · On-site

Writes / manages clinical trial protocols, protocol amendments, clinical study project timelines, clinical evaluations (planning and reports), risk master lists, clinical trial registrations and ...

Abbott

Writes / manages clinical trial protocols, protocol amendments, clinical study project timelines, clinical evaluations (planning and reports), risk master lists, clinical trial registrations and ...

Centerstone

Clinical Evaluator

Richmond, IN · On-site

$18.20 - $25.50/hr

... evaluation, and grant applications. • Comply with Quality Assurance procedures and clinical records regulations. • Complete all required trainings and evaluations. Time Type: Full time Pay Range ...

Intuitive

Senior Clinical Scientist

Sunnyvale, CA · On-site +1

The position will mainly focus on the development of Clinical Evaluation Plans (CEPs) & Clinical Evaluation Reports (CERs), with a potential for future additional responsibility in the development of ...

Sysmex

Director, Clinical Affairs

Lincolnshire, IL · On-site

$84K - $114K/yr

This position will be responsible for understanding the operating principles of the devices required, to develop preclinical and clinical evaluation plans including study protocols; determine study ...

Intuitive

Senior Clinical Scientist

Sunnyvale, CA

The position will mainly focus on the development of Clinical Evaluation Plans (CEPs) & Clinical Evaluation Reports (CERs), with a potential for future additional responsibility in the development of ...

Sysmex

Director, Clinical Affairs

Mundelein, IL · On-site

$81K - $111K/yr

This position will be responsible for understanding the operating principles of the devices required, to develop preclinical and clinical evaluation plans including study protocols; determine study ...

Sysmex

Director, Clinical Affairs

Lincolnshire, IL · On-site

$84K - $114K/yr

This position will be responsible for understanding the operating principles of the devices required, to develop preclinical and clinical evaluation plans including study protocols; determine study ...

previous pagenext page

Showing results 21-40

All JobsClinical Evaluation Jobs

Clinical Evaluation information

See salary details

$14

$34

$90

How much do clinical evaluation jobs pay per hour?

As of Aug 8, 2026, the average hourly pay for clinical evaluation in the United States is $34.62, according to ZipRecruiter salary data. Most workers in this role earn between $16.59 and $32.93 per hour, depending on experience, location, and employer.

What are some common challenges faced in a clinical evaluation role, and how can they be addressed?

Professionals in Clinical Evaluation often encounter challenges such as interpreting complex clinical data, ensuring regulatory compliance, and collaborating with cross-functional teams. Navigating varying regulatory requirements across regions (e.g., FDA vs. EU MDR) can be particularly demanding. Addressing these challenges requires strong analytical skills, ongoing education on regulatory updates, and effective communication with colleagues in clinical, regulatory, and quality departments. Building a network within the organization and staying current with industry best practices can also help mitigate these difficulties.

What is the difference between Clinical Evaluation vs Clinical Research Associate?

AspectClinical EvaluationClinical Research Associate
Required CredentialsMedical or healthcare background, certifications in clinical evaluationDegree in life sciences, certifications in clinical trial management
Work EnvironmentMedical device companies, regulatory agencies, healthcare settingsClinical trial sites, pharmaceutical companies, CROs
Employer & Industry UsageRegulatory compliance, product safety assessmentMonitoring clinical trials, data collection, site management

While both roles involve clinical expertise, Clinical Evaluation focuses on assessing medical device safety and performance for regulatory approval, whereas Clinical Research Associates primarily oversee and monitor clinical trials to ensure data integrity and compliance. Understanding these differences helps professionals choose the right career path or job search focus within the healthcare and medical device industries.

What is clinical evaluation?

Clinical evaluation is the systematic assessment and analysis of clinical data to verify the safety and performance of a medical device. This process involves reviewing scientific literature, clinical investigations, and post-market data to demonstrate that the device achieves its intended purpose without posing unacceptable risks to patients or users. Clinical evaluation is a regulatory requirement, especially for medical devices in the European Union, and must be updated regularly throughout the product’s lifecycle.

What are the key skills and qualifications needed to thrive in clinical evaluation?

To thrive in Clinical Evaluation, you need a solid background in medical or life sciences, analytical thinking, and familiarity with clinical research processes, often supported by a relevant degree. Experience with regulatory databases, clinical trial management systems (CTMS), and certifications like Good Clinical Practice (GCP) are typically required. Strong attention to detail, critical reasoning, and effective communication are vital soft skills for interpreting data and collaborating with cross-functional teams. These competencies ensure accurate assessment of clinical evidence, regulatory compliance, and the successful approval of medical products.
More about Clinical Evaluation jobs
What cities are hiring for Clinical Evaluation jobs? Cities with the most Clinical Evaluation job openings:
What are the most commonly searched types of Clinical Evaluation jobs? The most popular types of Clinical Evaluation jobs are:
What states have the most Clinical Evaluation jobs? States with the most job openings for Clinical Evaluation jobs include:
What job categories do people searching Clinical Evaluation jobs look for? The top searched job categories for Clinical Evaluation jobs are:
Clinical Evaluation jobs near you
Infographic showing various Clinical Evaluation job openings in the United States as of August 2026, with employment types broken down into 3% As Needed, 71% Full Time, 18% Part Time, and 8% Contract. Highlights an 95% Physical, 1% Hybrid, and 4% Remote job distribution, with an average salary of $72,002 per year, or $34.6 per hour.

Executive Director, Clinical Assessment & Evaluation

Menarini Group

Manhattan, NY • On-site

$350K - $420K/yr

Full-time

Medical, Life, Retirement

Re-posted 19 days ago

Job description

Overview
The Executive Director, Clinical Assessment & Evaluation is a physician responsible for supporting business development opportunities at pre-clinical and clinical stages, tasked with translating pre-clinical and early clinical oncology data into prospective, high-value clinical development plans. A key responsibility will be evaluating emerging modalities to determine their potential for clinical success and regulatory approval. Our mission is to build a portfolio of first-in-class assets that redefine the standard of care.
Responsibilities
Clinical Development Architecture
  • Comprehensive Clinical Foundation: Possess a deep-seated understanding of the current and emerging oncology landscape across the full spectrum of solid tumor malignancies (including GI, Thoracic, GU, etc.)
  • End-to-End Strategic Design: Lead the design of comprehensive Clinical Development Plans that bridge the gap from preclinical "Proof of Concept" to registrational success, ensuring every trial phase is optimized for speed and statistical significance.
  • Novel Design Conceptualization: Draft high-level innovative trial designs (e.g., umbrella, basket, or adaptive trials) for first-in-class assets to efficiently evaluate novel mechanisms of action (MoA).
  • Indication Prioritization: Use scientific and market data to determine which oncology indications offer the highest probability of success.

Due Diligence & Asset Evaluation
  • Clinical Evaluation: Provide clinical perspective on in-licensing opportunities, from early-stage platforms to late-stage assets.
  • Target Product Profiles (TPP): Develop and maintain TPPs for potential assets, ensuring they align with unmet medical needs and have a clear path to regulatory approval.
  • MoA Gatekeeping: Perform rigorous biological and clinical pressure-testing to every potential in-license opportunity and how it fits into the competitive landscape.

Competitive Intelligence
  • Anticipatory Analysis: Forecast the 5-10-year oncology landscape to align our assets with future shifts in the standard of care.
  • Conference Representation: Attend major global summits (AACR, ASCO, ESMO, SABCS), to monitor oncology trends and emerging landscape changes.
  • KOL Network: Maintain a network of world-class oncology Key Opinion Leaders to stress-test clinical hypotheses and development strategies.

Qualifications
Education:
  • MD is mandatory. •
    • Additionally, a PhD and/or MBA is highly desirable.
    • Board certification in Oncology or Hematology is a plus.
  • Experience: 12+ years of progressive experience in Clinical Development within biotech or pharma.
  • Possess and maintain a deep knowledge of the oncology landscape across solid tumors and a demonstrated ability to predict which scientific trends will yield clinical success.
  • Ability to interpret complex biomarker data, PK/PD modeling, and high-level biostatistical outputs.
  • A deep professional network within the oncology scientific community.
  • Proven experience in scientific due diligence for M&A or licensing deals. Confidence to act decisively and make strategic decisions.
  • Deep familiarity with FDA/EMA oncology guidance, including expedited pathways (Breakthrough Therapy, Fast Track, RMAT).

NOTE: Role is remote based, with expectations for business travel and onsite presence approx. 15%
Please note: This position is classified as a corporate office position. In accordance with the New York state employer convenience rule, Stemline will withhold New York state income taxes for all corporate office employees, regardless of whether these employees work in New York or remotely.
Base Salary Range of $350,000-$420,000 plus annual bonus & long-term Incentives. Menarini Stemline offers generous compensation and benefits packages, including, Fidelity 401(k) (with company match), Anthem Premier PPO and HDHP insurance plans, Company paid Basic Life & AD&D insurance and pre-tax FSA/HSA programs.
Menarini Stemline is committed to creating an inclusive environment for all employees. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran. Reasonable accommodations may be made to enable qualified individuals with disabilities to perform the essential functions.
#LI-MB1
Company Overview
The Menarini Group is an established Italian pharmaceutical company with a nearly 139-year history, founded in 1886 in Naples and headquartered in Florence. We operate globally based on five core pillars: high-quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation, strong people-centricity, and environmental sustainability.
Global Reach & Operations
  • Presence: We are present in 70 countries, and our products are sold in over 140 locations around the world.
  • Workforce: Our global operations are supported by approximately 18,000 employees.
  • Manufacturing Power: We are a major producer, manufacturing over 500 million packs of drugs annually across 18 manufacturing sites distributed across six continents.

Strategic Focus on Oncology
Menarini has made a significant global commitment to oncology, notably marking our entry into the US market with the acquisition of Stemline Therapeutics in June 2020. Our vision is to unify innovative therapeutics with advanced diagnostics for faster, more effective, and precise patient management.
  • Therapeutics: We have a robust pipeline focused on first in class and first to market investigational compounds for hematological and solid tumors with a specific focus on women's health including breast and gynecologic cancers. Key assets include:
    • Tagraxofusp: A novel, first-in-class targeted therapy and the only approved treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in the U.S. and E.U.
    • Selinexor: A first-in-class oral Selective Inhibitor of Nuclear Export compound for hematologic cancers and solid tumors, commercialized through an exclusive licensing agreement for Europe and other key territories.
    • Elacestrant: An oral SERD for hormone receptor-positive advanced breast cancer, fully developed and successfully launched in the US and EU following a global license agreement.
    • Other novel therapeutics under development include MEN2312, an oral KAT6 inhibitor as well as MEN2501.
  • Diagnostics: We invest heavily in the liquid biopsy diagnostic field through our affiliate, Menarini Silicon Biosystems (MSB), a pioneer in rare cell analysis and non-invasive, advanced diagnostics solutions.
    • MSB offers the CELLSEARCH® Circulating Tumor Cell (CTC) Test, the first and only FDA-cleared blood test for detecting and counting CTCs in metastatic breast, prostate, and colorectal cancer when used in conjunction with other clinical monitoring methods.
    • In 2022, we launched the first-of-its-kind CELLSEARCH® Circulating Multiple Myeloma Cell (CMMC) Enumeration LDT, providing a minimally invasive approach to assess plasma cell burden.

This is an exciting and transformative time for the organization. Joining Menarini Stemline offers a significant opportunity to contribute directly to shaping the future of our expanding global Oncology business.

Apply